Metabolomics profiling for identification of novel potential markers in early prediction of preeclampsia.

PLoS One 2014 29;9(5):e98540. Epub 2014 May 29.

Leiden Academic Center for Drug Research, Division of Analytical Biosciences, Leiden University, Leiden, The Netherlands; The Netherlands Metabolomics Centre, Leiden University, Leiden, the Netherlands.

Objective: The first aim was to investigate specific signature patterns of metabolites that are significantly altered in first-trimester serum of women who subsequently developed preeclampsia (PE) compared to healthy pregnancies. The second aim of this study was to examine the predictive performance of the selected metabolites for both early onset [EO-PE] and late onset PE [LO-PE].

Methods: This was a case-control study of maternal serum samples collected between 8+0 and 13+6 weeks of gestation from 167 women who subsequently developed EO-PE n = 68; LO-PE n = 99 and 500 controls with uncomplicated pregnancies. Metabolomics profiling analysis was performed using two methods. One has been optimized to target eicosanoids/oxylipins, which are known inflammation markers and the other targets compounds containing a primary or secondary biogenic amine group. Logistic regression analyses were performed to predict the development of PE using metabolites alone and in combination with first trimester mean arterial pressure (MAP) measurements.

Results: Two metabolites were significantly different between EO-PE and controls (taurine and asparagine) and one in case of LO-PE (glycylglycine). Taurine appeared the most discriminative biomarker and in combination with MAP predicted EO-PE with a detection rate (DR) of 55%, at a false-positive rate (FPR) of 10%.

Conclusion: Our findings suggest a potential role of taurine in both PE pathophysiology and first trimester screening for EO-PE.

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0098540PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4038585PMC
January 2015
17 Reads

Publication Analysis

Top Keywords

subsequently developed
8
women subsequently
8
metabolomics profiling
8
8+0 13+6
4
predicted eo-pe
4
collected 8+0
4
samples collected
4
biogenic amine
4
map predicted
4
13+6 weeks
4
gestation 167
4
167 women
4
combination map
4
weeks gestation
4
controls taurine
4
eo-pe detection
4
arterial pressure
4
[eo-pe] late
4
late onset
4
amine group
4

References

(Supplied by CrossRef)
Geographic variation in the incidence of hypertension in pregnancy. World Health Organization International Collaborative Study of Hypertensive Disorders of Pregnancy
Am J Obstet Gynecol
Pre-eclampsia
B Sibai et al.
Lancet 26 2005
The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP)
MA Brown et al.
Hypertens Pregnancy 2001
Inflammation and pre-eclampsia
AM Borzychowski et al.
Semin Fetal Neonatal Med 2006
Latest advances in understanding preeclampsia
CW Redman et al.
Science 10 2005
Endothelial dysfunction in preeclampsia
JM Roberts et al.
Semin Reprod Endocrinol 1998

Similar Publications